Showing results (21-30 of 98) with videos related to

Sort By:
Pageof 10
Diagnostic Microbiology and Infectious Disease|June 8, 2021
In vitro activity of imipenem-relebactam against various resistance phenotypes/genotypes of Enterobacterales and Pseudomonas aeruginosa isolated from patients across Canada as part of the CANWARD study, 2016-2019Andrew Walkty, James A Karlowsky, Melanie R Baxter, et al.
Microbial Genomics|June 11, 2026
Rapid identification of microbial pathogens and antimicrobial resistance from bloodstream infections using long-read sequencingNicole Lerminiaux, Ken Fakharuddin, Heather J Adam, et al.
The Journal of Antimicrobial Chemotherapy|April 17, 2013
Changes in fluoroquinolone resistance over 5 years (CANWARD 2007-11) in bacterial pathogens isolated in Canadian hospitalsJames A Karlowsky, Heather J Adam, Marc Desjardins, et al.
Diagnostic Microbiology and Infectious Disease|February 22, 2020
In Vitro Activity of Cefiderocol, a Novel Siderophore Cephalosporin, against Gram-Negative Bacilli Isolated from Patients in Canadian Intensive Care UnitsAlyssa R Golden, Heather J Adam, Melanie Baxter, et al.
The Journal of Antimicrobial Chemotherapy|August 28, 2025
Distribution and antimicrobial susceptibility profile of pathogens recovered from the bloodstream of Canadian patients: results from the CANWARD study (2007-23)Andrew Walkty, Heather J Adam, Melanie Baxter, et al.
The Journal of Antimicrobial Chemotherapy|September 30, 2022
In vitro activity of sulopenem against 1880 bacterial pathogens isolated from Canadian patients with urinary tract infections (CANWARD, 2014-21)Andrew J Walkty, James A Karlowsky, Melanie R Baxter, et al.
Microbial Drug Resistance (Larchmont, N.Y.)|December 30, 2011
Baseline epidemiology of Streptococcus pneumoniae serotypes in Canada prior to the introduction of the 13-valent pneumococcal vaccineHeather J Adam, James A Karlowsky, Kimberly A Nichol, et al.
Diagnostic Microbiology and Infectious Disease|April 15, 2025
In Vitro activity of ceftobiprole against 20,255 recent clinical bacterial isolates in Canada (CANWARD 2015-2023)Élodie Gemme, Andrew Walkty, Melanie Baxter, et al.
The Journal of Antimicrobial Chemotherapy|August 2, 2024
Phenotypic and molecular characterization of Streptococcus pneumoniae serotype 3 isolates from blood and respiratory samples in Canada: CANWARD 2007-21John J Schellenberg, Heather J Adam, Melanie R Baxter, et al.
Diagnostic Microbiology and Infectious Disease|June 30, 2021
Invasive pneumococcal disease caused by serotypes 22F and 33F in Canada: the SAVE study 2011-2018Alyssa R Golden, Thomas Fear, Melanie Baxter, et al.
Pageof 10